Geun-Woo Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Geun-Woo Kim has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Eun Cho
College of Pharmacy, Sookmyung Women’s University, Seoul, Republic of Korea
3 shared publications - So-Young Lee
College of Pharmacy, Sookmyung Women’s University, Seoul, Republic of Korea
3 shared publications - Byung-Soo Koo
Department of Oriental Neuropsychiatry, Graduate School of Dongguk University, Seoul 04620, Republic of Korea
2 shared publications - Eun-Jung Kim
Department of Acupuncture & Moxibustion, Dongguk University Bundang Oriental Hospital, Seongnam-si, Republic of Korea
2 shared publications - Hyung Won Kang
Department of Korean Neuropsychiatry Medicine, College of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea
2 shared publications - Ji-Eun Lee
College of Pharmacy, Sookmyung Women’s University, Seoul, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by The Society of Korean Medicine in Journal of Korean Medicine
- Vol. 47 (2) , 216-225
Clinical Characteristics and Medical Utilization Patterns of Inpatient Hospice Patients in a Korean Medicine Hospital: A Retrospective Chart Review
Objectives: This study investigated the clinical characteristics and medical utilization patterns of terminally ill inpatients admitted to hospice center in Korean medicine(KM) hospital.Methods: The electronic medical records of terminally ill patients admitted to hospice center in KM hospital from September 2024 to December 2025 were retrospectively reviewed. Demographic characteristics, referral source, length of stay, and end-of-life information(The use of the dying room, physicians who declared death) were collected. Additionally, for patients hospitalized for more than 4 days, additional information(Eastern Cooperative Oncology Group(ECOG), Numeric Rating Scale(NRS), and Faces Pain Rating Scale(FPRS)) were investigated.Results: A total of 120 cases except 6 survivors were analyzed. Among 120 cases, 96 patients died in the hospital and 24 patients were discharged. The length of stay after admission was found to be within 7 days for 51.7% of patients and within 14 days for 77.5%. 79.2% of patients utilized the dying room. Declarations of death occurred more frequently at night and KM doctors were responsible for 88.5%. For patients hospitalized for 4 days or longer, the length of stay decreased as ECOG, NRS, and FPRS scores declined.Conclusions: The characteristics and utilization patterns of patients were similar to national hospice data. It was also confirmed that KM doctors played a specific role in end-of-life care, suggesting that they contribute to the provision of multidisciplinary hospice services. Further multi-center studies including diverse patient groups are deemed necessary.
- 1 June 2026
- Published by The Society of Korean Medicine in Journal of Korean Medicine
- Vol. 47 (2) , 216-225
Open AccessClinical Characteristics and Medical Utilization Patterns of Inpatient Hospice Patients in a Korean Medicine Hospital: A Retrospective Chart Review
Objectives: This study investigated the clinical characteristics and medical utilization patterns of terminally ill inpatients admitted to hospice center in Korean medicine(KM) hospital.Methods: The electronic medical records of terminally ill patients admitted to hospice center in KM hospital from September 2024 to December 2025 were retrospectively reviewed. Demographic characteristics, referral source, length of stay, and end-of-life information(The use of the dying room, physicians who declared death) were collected. Additionally, for patients hospitalized for more than 4 days, additional information(Eastern Cooperative Oncology Group(ECOG), Numeric Rating Scale(NRS), and Faces Pain Rating Scale(FPRS)) were investigated.Results: A total of 120 cases except 6 survivors were analyzed. Among 120 cases, 96 patients died in the hospital and 24 patients were discharged. The length of stay after admission was found to be within 7 days for 51.7% of patients and within 14 days for 77.5%. 79.2% of patients utilized the dying room. Declarations of death occurred more frequently at night and KM doctors were responsible for 88.5%. For patients hospitalized for 4 days or longer, the length of stay decreased as ECOG, NRS, and FPRS scores declined.Conclusions: The characteristics and utilization patterns of patients were similar to national hospice data. It was also confirmed that KM doctors played a specific role in end-of-life care, suggesting that they contribute to the provision of multidisciplinary hospice services. Further multi-center studies including diverse patient groups are deemed necessary.
- Open Access
- 5 July 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (13) , 1345
The Mental Health Outcomes and Cost Estimates of Korean Medicine for Anxiety Disorder Patients
Korean medicine (KM) is used to treat anxiety disorders, but there is limited research on its effects. This study aimed to examine the associations between improved QoL and reduced clinical symptoms and KM in patients with anxiety disorders. The medical records of patients with anxiety who were treated with KM (acupuncture, psychotherapy, Chuna therapy, aromatherapy, or herbal medicine) for at least 4 weeks were retrospectively analyzed. Clinical, QoL, and cost outcomes were measured at baseline and at weeks 4 and 12 (Anxiety: State-Trait Anxiety Inventory [STAI X-1 (state), X-2 (trait)], Beck Anxiety Inventory [BAI]; anger: State-Trait Anger Expression Inventory State [STAXI-S (state), T (trait)], Anger Expression Inventory [AXI-K-I (anger-in), AXI-K-O (anger-out), AXI-K-C (anger-control); depression: Beck Depression Inventory-II [BDI II], QoL: QoL-related instruments Euro Quality of Life 5 Dimensions utility score [EQ-5D], Euro QoL Visual Analog Scale [EQ-VAS]). The total costs for each item were calculated in terms of NHIS-covered costs and patients’ out-of-pocket costs from the perspective of the healthcare system. The medical records of 67 patients were evaluated. The KM treatments were found to be associated with decreased anxiety (STAI X-1; STAI X-2; BAI, p < 0.0001), depression (BDI-II, p < 0.0001), and anger (AKI-K-I; AKI-K-O, p < 0.05) and increased QoL (EQ-5D; EQ-VAS, p < 0.0001). An average of USD 1360 was paid for the KM treatments for 4 weeks. The study findings suggested that KM may improve clinical symptoms and QoL outcomes in patients with anxiety disorders.
- 5 July 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (13) , 1345
Open AccessThe Mental Health Outcomes and Cost Estimates of Korean Medicine for Anxiety Disorder Patients
Korean medicine (KM) is used to treat anxiety disorders, but there is limited research on its effects. This study aimed to examine the associations between improved QoL and reduced clinical symptoms and KM in patients with anxiety disorders. The medical records of patients with anxiety who were treated with KM (acupuncture, psychotherapy, Chuna therapy, aromatherapy, or herbal medicine) for at least 4 weeks were retrospectively analyzed. Clinical, QoL, and cost outcomes were measured at baseline and at weeks 4 and 12 (Anxiety: State-Trait Anxiety Inventory [STAI X-1 (state), X-2 (trait)], Beck Anxiety Inventory [BAI]; anger: State-Trait Anger Expression Inventory State [STAXI-S (state), T (trait)], Anger Expression Inventory [AXI-K-I (anger-in), AXI-K-O (anger-out), AXI-K-C (anger-control); depression: Beck Depression Inventory-II [BDI II], QoL: QoL-related instruments Euro Quality of Life 5 Dimensions utility score [EQ-5D], Euro QoL Visual Analog Scale [EQ-VAS]). The total costs for each item were calculated in terms of NHIS-covered costs and patients’ out-of-pocket costs from the perspective of the healthcare system. The medical records of 67 patients were evaluated. The KM treatments were found to be associated with decreased anxiety (STAI X-1; STAI X-2; BAI, p < 0.0001), depression (BDI-II, p < 0.0001), and anger (AKI-K-I; AKI-K-O, p < 0.05) and increased QoL (EQ-5D; EQ-VAS, p < 0.0001). An average of USD 1360 was paid for the KM treatments for 4 weeks. The study findings suggested that KM may improve clinical symptoms and QoL outcomes in patients with anxiety disorders.
- Open Access
- 9 May 2024
- Published by MDPI AG in Preprints.org
The Effectiveness and Cost Outcomes of Korean Medicine for Anxiety Disorders: A Retrospective Case Series Study
Anxiety disorders affect patient quality of life (QoL). This study aimed to examine the associations between improved QoL and reduced clinical symptoms and Korean medicine (KM) in patients with anxiety disorders. Medical records of patients with anxiety who were treated with KM (acupuncture, Anxiety disorders affect patient quality of life (QoL). This study aimed to examine the associations between improved QoL and reduced clinical symptoms and Korean medicine (KM) in patients with anxiety disorders. Medical records of patients with anxiety who were treated with KM (ac-upuncture, psychotherapy, Chuna therapy, aromatherapy, or herbal medicine) for at least 4 weeks were retrospectively analyzed. Clinical, QoL, and cost outcomes were measured at baseline and at 4 and 12 weeks (Anxiety: State-Trait Anxiety Inventory[STAI X-1(state), X-2(trait)], Beck Anxiety Inventory[BAI]; anger: State-Trait Anger Expression Inventory State[STAXI-S(state), T(trait)], Anger Expression Inventory[AXI-K-I(anger-in), AXI-K-O(anger-out), AXI-K-C(anger-control); depression: Beck Depression Inventory-II[BDI II], QoL: QoL-related instruments Euro Quality of Life 5 Dimensions utility score[EQ-5D], Euro QoL Visual Analog Scale[EQ-VAS]). The quali-ty-adjusted life years (QALYs) and average cost-effectiveness ratio of KM for anxiety were esti-mated. The medical records for 67 patients were evaluated. KM treatments were found to be as-sociated with decreased anxiety (STAI X-1; STAI X-2; BAI, p
- 9 May 2024
- Published by MDPI AG in Preprints.org
Open AccessThe Effectiveness and Cost Outcomes of Korean Medicine for Anxiety Disorders: A Retrospective Case Series Study
Anxiety disorders affect patient quality of life (QoL). This study aimed to examine the associations between improved QoL and reduced clinical symptoms and Korean medicine (KM) in patients with anxiety disorders. Medical records of patients with anxiety who were treated with KM (acupuncture, Anxiety disorders affect patient quality of life (QoL). This study aimed to examine the associations between improved QoL and reduced clinical symptoms and Korean medicine (KM) in patients with anxiety disorders. Medical records of patients with anxiety who were treated with KM (ac-upuncture, psychotherapy, Chuna therapy, aromatherapy, or herbal medicine) for at least 4 weeks were retrospectively analyzed. Clinical, QoL, and cost outcomes were measured at baseline and at 4 and 12 weeks (Anxiety: State-Trait Anxiety Inventory[STAI X-1(state), X-2(trait)], Beck Anxiety Inventory[BAI]; anger: State-Trait Anger Expression Inventory State[STAXI-S(state), T(trait)], Anger Expression Inventory[AXI-K-I(anger-in), AXI-K-O(anger-out), AXI-K-C(anger-control); depression: Beck Depression Inventory-II[BDI II], QoL: QoL-related instruments Euro Quality of Life 5 Dimensions utility score[EQ-5D], Euro QoL Visual Analog Scale[EQ-VAS]). The quali-ty-adjusted life years (QALYs) and average cost-effectiveness ratio of KM for anxiety were esti-mated. The medical records for 67 patients were evaluated. KM treatments were found to be as-sociated with decreased anxiety (STAI X-1; STAI X-2; BAI, p
- Open Access
- 15 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2313
Antioxidant Efficacy of Hwangryunhaedok-tang through Nrf2 and AMPK Signaling Pathway against Neurological Disorders In Vivo and In Vitro
Alzheimer’s disease (AD) is a representative cause of dementia and is caused by neuronal loss, leading to the accumulation of aberrant neuritic plaques and the formation of neurofibrillary tangles. Oxidative stress is involved in the impaired clearance of amyloid beta (Aβ), and Aβ-induced oxidative stress causes AD by inducing the formation of neurofibrillary tangles. Hwangryunhaedok-tang (HHT, Kracie K-09®), a traditional herbal medicine prescription, has shown therapeutic effects on various diseases. However, the studies of HHT as a potential treatment for AD are insufficient. Therefore, our study identified the neurological effects and mechanisms of HHT and its key bioactive compounds against Alzheimer’s disease in vivo and in vitro. In a 5xFAD mouse model, our study confirmed that HHT attenuated cognitive impairments in the Morris water maze (MWM) test and passive avoidance (PA) test. In addition, the prevention of neuron impairment, reduction in the protein levels of Aβ, and inhibition of cell apoptosis were confirmed with brain tissue staining. In HT-22 cells, HHT attenuates tBHP-induced cytotoxicity, ROS generation, and mitochondrial dysfunction. It was verified that HHT exerts a neuroprotective effect by activating signaling pathways interacting with Nrf2, such as MAPK/ERK, PI3K/Akt, and LKB1/AMPK. Among the components, baicalein, a bioavailable compound of HHT, exhibited neuroprotective properties and activated the Akt, AMPK, and Nrf2/HO-1 pathways. Our findings indicate a mechanism for HHT and its major bioavailable compounds to treat and prevent AD and suggest its potential.
- 15 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2313
Open AccessAntioxidant Efficacy of Hwangryunhaedok-tang through Nrf2 and AMPK Signaling Pathway against Neurological Disorders In Vivo and In Vitro
Alzheimer’s disease (AD) is a representative cause of dementia and is caused by neuronal loss, leading to the accumulation of aberrant neuritic plaques and the formation of neurofibrillary tangles. Oxidative stress is involved in the impaired clearance of amyloid beta (Aβ), and Aβ-induced oxidative stress causes AD by inducing the formation of neurofibrillary tangles. Hwangryunhaedok-tang (HHT, Kracie K-09®), a traditional herbal medicine prescription, has shown therapeutic effects on various diseases. However, the studies of HHT as a potential treatment for AD are insufficient. Therefore, our study identified the neurological effects and mechanisms of HHT and its key bioactive compounds against Alzheimer’s disease in vivo and in vitro. In a 5xFAD mouse model, our study confirmed that HHT attenuated cognitive impairments in the Morris water maze (MWM) test and passive avoidance (PA) test. In addition, the prevention of neuron impairment, reduction in the protein levels of Aβ, and inhibition of cell apoptosis were confirmed with brain tissue staining. In HT-22 cells, HHT attenuates tBHP-induced cytotoxicity, ROS generation, and mitochondrial dysfunction. It was verified that HHT exerts a neuroprotective effect by activating signaling pathways interacting with Nrf2, such as MAPK/ERK, PI3K/Akt, and LKB1/AMPK. Among the components, baicalein, a bioavailable compound of HHT, exhibited neuroprotective properties and activated the Akt, AMPK, and Nrf2/HO-1 pathways. Our findings indicate a mechanism for HHT and its major bioavailable compounds to treat and prevent AD and suggest its potential.
- Open Access
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31456
Efficacy and safety evaluation of adjuvant auricular acupuncture for smoking cessation: A study protocol of randomized, assessor-blinded, pragmatic pilot trial
Background: Smoking negatively impacts public health. There are several treatments to quit smoking, and nicotine replacement treatment (NRT) reportedly doubles the smoking cessation rate, with some limitations. Acupuncture is an alternative option with proven effects on smoking cessation. However, there has been no definite report that indicates the efficacy and safety of auricular acupuncture (AA) combined with NRT on smoking cessation. Methods: This is a randomized, assessor-blind, and pragmatic pilot study. We will recruit 40 participants who want to stop smoking and randomly allocate them into an NRT group and an NRT + AA group with a 1:1 ratio. Participants will receive NRT for 4 weeks and the NRT + AA group will receive additional AA treatment with 5 AA points (Shenmen (TF4), lung (CO14), throat (TF3), inner nose (TG4), and endocrine (CO18)) twice a week for 4 weeks. Follow-up will be conducted 1 and 3 months after intervention completion. The primary outcome will be tobacco consumption and abstinence rate determined by calculating the rate of change in cigarette use and a urine test. Secondary outcomes will be the quality of life (EuroQol-5D and visual analogue scale), nicotine dependence (Fagerstrom test for nicotine dependence), nicotine withdrawal (Minnesota nicotine withdrawal scale), physical effects, satisfaction, and safety measurement (adverse events). Results: We will investigate the efficacy and safety of AA combined with NRT treatment for smoking cessation. Conclusion: Our study will provide additional clinical evidence for AA as an adjuvant treatment for smoking cessation. Trial registration number: Clinical Research Information Service (registration number: KCT0007212).
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31456
Open AccessEfficacy and safety evaluation of adjuvant auricular acupuncture for smoking cessation: A study protocol of randomized, assessor-blinded, pragmatic pilot trial
Background: Smoking negatively impacts public health. There are several treatments to quit smoking, and nicotine replacement treatment (NRT) reportedly doubles the smoking cessation rate, with some limitations. Acupuncture is an alternative option with proven effects on smoking cessation. However, there has been no definite report that indicates the efficacy and safety of auricular acupuncture (AA) combined with NRT on smoking cessation. Methods: This is a randomized, assessor-blind, and pragmatic pilot study. We will recruit 40 participants who want to stop smoking and randomly allocate them into an NRT group and an NRT + AA group with a 1:1 ratio. Participants will receive NRT for 4 weeks and the NRT + AA group will receive additional AA treatment with 5 AA points (Shenmen (TF4), lung (CO14), throat (TF3), inner nose (TG4), and endocrine (CO18)) twice a week for 4 weeks. Follow-up will be conducted 1 and 3 months after intervention completion. The primary outcome will be tobacco consumption and abstinence rate determined by calculating the rate of change in cigarette use and a urine test. Secondary outcomes will be the quality of life (EuroQol-5D and visual analogue scale), nicotine dependence (Fagerstrom test for nicotine dependence), nicotine withdrawal (Minnesota nicotine withdrawal scale), physical effects, satisfaction, and safety measurement (adverse events). Results: We will investigate the efficacy and safety of AA combined with NRT treatment for smoking cessation. Conclusion: Our study will provide additional clinical evidence for AA as an adjuvant treatment for smoking cessation. Trial registration number: Clinical Research Information Service (registration number: KCT0007212).
- Open Access
- 11 October 2021
- Published by MDPI AG in Healthcare
- Vol. 9 (10) , 1351
Effectiveness, Cost-Utility, and Safety of Neurofeedback Self-Regulating Training in Patients with Post-Traumatic Stress Disorder: A Randomized Controlled Trial
Post-traumatic stress disorder (PTSD) is characterized by neurophysiological and psycho-emotional problems after exposure to trauma. Several pharmacological and psychotherapy limitations, such as adverse events and low adherence, increase the need for alternative therapeutic options. Neurofeedback is widely used for PTSD management. However, evidence of its clinical efficacy is lacking. We conducted a randomized, waitlist-controlled, assessor-blinded clinical trial to assess the effectiveness, cost-utility, and safety of 16 sessions of neurofeedback on people with PTSD for eight weeks. Eleven participants were allocated to each group. One and two subjects dropped out from the neurofeedback and control groups, respectively. The primary outcome was PTSD symptom change evaluated using the PTSD Checklist-5 (PCL-5-K). The PCL-5-K levels improved more in the neurofeedback group (44.3 ± 10.8 to 19.4 ± 7.75) than in the control group (35.1 ± 18.5 to 31.0 ± 14.92). The change value was significantly improved in the neurofeedback group (24.90 ± 13.13 vs. 4.11 ± 9.03). Secondary outcomes such as anxiety, depression, insomnia, and quality of life were also improved. In an economic analysis using EuroQol-5D, the incremental cost-per-quality-adjusted life-year was approximately $15,600, indicating acceptable cost-utility. There were no adverse events in either group. In conclusion, neurofeedback might be a useful, cost-effective, and safe intervention for PTSD management.
- 11 October 2021
- Published by MDPI AG in Healthcare
- Vol. 9 (10) , 1351
Open AccessEffectiveness, Cost-Utility, and Safety of Neurofeedback Self-Regulating Training in Patients with Post-Traumatic Stress Disorder: A Randomized Controlled Trial
Post-traumatic stress disorder (PTSD) is characterized by neurophysiological and psycho-emotional problems after exposure to trauma. Several pharmacological and psychotherapy limitations, such as adverse events and low adherence, increase the need for alternative therapeutic options. Neurofeedback is widely used for PTSD management. However, evidence of its clinical efficacy is lacking. We conducted a randomized, waitlist-controlled, assessor-blinded clinical trial to assess the effectiveness, cost-utility, and safety of 16 sessions of neurofeedback on people with PTSD for eight weeks. Eleven participants were allocated to each group. One and two subjects dropped out from the neurofeedback and control groups, respectively. The primary outcome was PTSD symptom change evaluated using the PTSD Checklist-5 (PCL-5-K). The PCL-5-K levels improved more in the neurofeedback group (44.3 ± 10.8 to 19.4 ± 7.75) than in the control group (35.1 ± 18.5 to 31.0 ± 14.92). The change value was significantly improved in the neurofeedback group (24.90 ± 13.13 vs. 4.11 ± 9.03). Secondary outcomes such as anxiety, depression, insomnia, and quality of life were also improved. In an economic analysis using EuroQol-5D, the incremental cost-per-quality-adjusted life-year was approximately $15,600, indicating acceptable cost-utility. There were no adverse events in either group. In conclusion, neurofeedback might be a useful, cost-effective, and safe intervention for PTSD management.
- Open Access
- 1 December 2020
- Published by Elsevier in Integrative Medicine Research
- Vol. 9 (4) , 100464
Neurofeedback self-regulating training in patients with post traumatic stress disorder: a randomized controlled trial study protocol
- 1 December 2020
- Published by Elsevier in Integrative Medicine Research
- Vol. 9 (4) , 100464
Open AccessNeurofeedback self-regulating training in patients with post traumatic stress disorder: a randomized controlled trial study protocol
- Open Access
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1)
Patterns of Integrative Korean Medicine Practice for Anxiety Disorders: A Survey among Korean Medicine Doctors (KMDs) in Korea
Anxiety disorder is known as the most common disease among psychiatric disorders. However, many studies have not been conducted in the Korean medicine area. This study explores the current state of anxiety disorder treatments of Korean medicine through a survey research. The survey for Korean medicine doctors (KMDs) on Korean medicine (KM) diagnosis and treatments for anxiety disorder was conducted online from December 21, 2016, to December 29, 2016. The results were divided into two groups, KMDs and Korean medicine neuropsychiatric specialists (KMNPS), and comparatively analyzed. Self‐evaluation and counseling were the most common in both diagnostic methods and evaluation of treatment effects, and KMNPS tended to make extensive use of objective indicators. There was no difference in the rate of psychiatric medication use among the patients between KMD and KMNPS. The main reason for patients wanting KM treatment was the tapering cessation of psychiatric medications. The most common treatments were acupuncture, herbal medicine, and moxibustion, in addition to dry cupping in KMD and psychotherapy in KMNPS. The most important factor for treatment was herbal medicine treatment, followed by rapport formation in KMD and patient’s temperament in KMNPS. Opinions on various items were presented as treatment barriers, and KMNPS tended to think more importantly about the patient’s family problems. For the items to be additionally trained in the future, KMD chose the diagnostic tools and KMNPS chose psychotherapies. This study is the first study to analyze the clinical patterns for anxiety disorder in KMDs. KMD and KMNPS showed similar patterns in the perception, diagnosis, and treatment of anxiety disorders, but KMNPS tended to use objective indicators and psychotherapy more actively. Further clinical studies for the development of clinical guidelines should be additionally required.
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1)
Open AccessPatterns of Integrative Korean Medicine Practice for Anxiety Disorders: A Survey among Korean Medicine Doctors (KMDs) in Korea
Anxiety disorder is known as the most common disease among psychiatric disorders. However, many studies have not been conducted in the Korean medicine area. This study explores the current state of anxiety disorder treatments of Korean medicine through a survey research. The survey for Korean medicine doctors (KMDs) on Korean medicine (KM) diagnosis and treatments for anxiety disorder was conducted online from December 21, 2016, to December 29, 2016. The results were divided into two groups, KMDs and Korean medicine neuropsychiatric specialists (KMNPS), and comparatively analyzed. Self‐evaluation and counseling were the most common in both diagnostic methods and evaluation of treatment effects, and KMNPS tended to make extensive use of objective indicators. There was no difference in the rate of psychiatric medication use among the patients between KMD and KMNPS. The main reason for patients wanting KM treatment was the tapering cessation of psychiatric medications. The most common treatments were acupuncture, herbal medicine, and moxibustion, in addition to dry cupping in KMD and psychotherapy in KMNPS. The most important factor for treatment was herbal medicine treatment, followed by rapport formation in KMD and patient’s temperament in KMNPS. Opinions on various items were presented as treatment barriers, and KMNPS tended to think more importantly about the patient’s family problems. For the items to be additionally trained in the future, KMD chose the diagnostic tools and KMNPS chose psychotherapies. This study is the first study to analyze the clinical patterns for anxiety disorder in KMDs. KMD and KMNPS showed similar patterns in the perception, diagnosis, and treatment of anxiety disorders, but KMNPS tended to use objective indicators and psychotherapy more actively. Further clinical studies for the development of clinical guidelines should be additionally required.
- Open Access
- 1 April 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (14) , e0266
Acupuncture for anxiety
Background: Acupuncture has been widely, used in Asian countries since the Yuan Dynasty in China. Moreover, acupuncture has been reported to exhibit anti-allergy effects in many clinical trials. This systematic review will assess the effectiveness, and safety of acupuncture for anxiety treatment. Methods: Eleven databases, including Asian databases, will be searched for studies conducted through December in the year 2017. We will include randomized controlled trials (RCTs) assessing acupuncture for anxiety. The risk of bias will be evaluated using the Cochrane risk of bias assessment tool, and confidence in the cumulative evidence will be evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) instrument. Ethics and dissemination: This systematic review will be published in a peer-reviewed journal. It will also be disseminated electronically, and in print. The review will be updated to inform, and guide healthcare practices. Registration number: PROSPERO 2018 under number CRD42018080034.
- 1 April 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (14) , e0266
Open AccessAcupuncture for anxiety
Background: Acupuncture has been widely, used in Asian countries since the Yuan Dynasty in China. Moreover, acupuncture has been reported to exhibit anti-allergy effects in many clinical trials. This systematic review will assess the effectiveness, and safety of acupuncture for anxiety treatment. Methods: Eleven databases, including Asian databases, will be searched for studies conducted through December in the year 2017. We will include randomized controlled trials (RCTs) assessing acupuncture for anxiety. The risk of bias will be evaluated using the Cochrane risk of bias assessment tool, and confidence in the cumulative evidence will be evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) instrument. Ethics and dissemination: This systematic review will be published in a peer-reviewed journal. It will also be disseminated electronically, and in print. The review will be updated to inform, and guide healthcare practices. Registration number: PROSPERO 2018 under number CRD42018080034.
- Open Access
- 28 November 2014
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 22 (1) , 1-11
Alteration in brain-derived neurotrophic factor (BDNF) after treatment of mice with herbal mixture containing Euphoria longana, Houttuynia cordata and Dioscorea japonica
Literature data indicate that brain-derived neurotrophic factor (BDNF), cyclic-AMP response element-binding protein (CREB) and phospho-CREB (pCREB) may hav
- 28 November 2014
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 22 (1) , 1-11
Open AccessAlteration in brain-derived neurotrophic factor (BDNF) after treatment of mice with herbal mixture containing Euphoria longana, Houttuynia cordata and Dioscorea japonica
Literature data indicate that brain-derived neurotrophic factor (BDNF), cyclic-AMP response element-binding protein (CREB) and phospho-CREB (pCREB) may hav